Resmed (RSMDF) EPS (Diluted) Growth (1y) (2010 - 2026)
Powered by 
Analysis
Resmed (RSMDF) EPS (Diluted) Growth (1y) (2010 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 184.06 Bn | 178.46 Bn | 7.27 Bn | -47.60% |
| 2 | Intuitive Surgical | 124.29 Bn | 119.08 Bn | 1.96 Bn | 26.30% |
| 3 | Medtronic | 118.26 Bn | 109.44 Bn | 6.34 Bn | 41.58% |
| 4 | Stryker | 104.56 Bn | 101.08 Bn | 4.50 Bn | 44.49% |
| 5 | Boston Scientific | 66.33 Bn | 65.79 Bn | 3.85 Bn | 15.24% |
| 6 | Edwards Lifesciences | 49.62 Bn | 45.37 Bn | 1.35 Bn | -25.88% |
| 7 | Alcon | 33.94 Bn | 32.48 Bn | 1.68 Bn | - |
| 8 | Dexcom | 32.18 Bn | 30.23 Bn | 830.00 Mn | 44.97% |
| 9 | Steris | 21.14 Bn | 20.65 Bn | 684.20 Mn | 13.96% |
| 10 | Resmed | 3.54 Bn | 2.07 Bn | 861.22 Mn | 1.87% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.87% |
| Mar 31, 2026 | 10.35% |
| Dec 31, 2025 | 14.78% |
| Sep 30, 2025 | 12.48% |
| Jun 30, 2025 | 30.12% |
| Mar 31, 2025 | 21.67% |
| Dec 31, 2024 | 65.12% |
| Sep 30, 2024 | 41.79% |
| Jun 30, 2024 | 27.16% |
| Mar 31, 2024 | 29.20% |
| Dec 31, 2023 | -7.25% |
| Sep 30, 2023 | 4.00% |
| Jun 30, 2023 | 17.41% |
| Mar 31, 2023 | 29.50% |
| Dec 31, 2022 | 11.20% |
| Sep 30, 2022 | 3.18% |
| Jun 30, 2022 | -0.42% |
| Mar 31, 2022 | 325.85% |
| Dec 31, 2021 | 11.91% |
| Sep 30, 2021 | 13.56% |